EP3000836B1 - Agent de réticulation photodégradable - Google Patents
Agent de réticulation photodégradable Download PDFInfo
- Publication number
- EP3000836B1 EP3000836B1 EP14801820.3A EP14801820A EP3000836B1 EP 3000836 B1 EP3000836 B1 EP 3000836B1 EP 14801820 A EP14801820 A EP 14801820A EP 3000836 B1 EP3000836 B1 EP 3000836B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- photodegradable
- cells
- gel
- cell culture
- photodegradable gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Not-in-force
Links
- 239000003431 cross linking reagent Substances 0.000 title claims description 103
- 239000000499 gel Substances 0.000 claims description 337
- 238000004113 cell culture Methods 0.000 claims description 145
- 150000001875 compounds Chemical class 0.000 claims description 100
- 238000000034 method Methods 0.000 claims description 83
- 239000002202 Polyethylene glycol Substances 0.000 claims description 63
- 229920001223 polyethylene glycol Polymers 0.000 claims description 63
- 239000000758 substrate Substances 0.000 claims description 63
- 229920000642 polymer Polymers 0.000 claims description 61
- 108010010803 Gelatin Proteins 0.000 claims description 41
- 229920000159 gelatin Polymers 0.000 claims description 41
- 239000008273 gelatin Substances 0.000 claims description 41
- 235000019322 gelatine Nutrition 0.000 claims description 41
- 235000011852 gelatine desserts Nutrition 0.000 claims description 41
- 125000004185 ester group Chemical group 0.000 claims description 27
- 125000003277 amino group Chemical group 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 25
- 238000012258 culturing Methods 0.000 claims description 24
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 19
- 230000004956 cell adhesive effect Effects 0.000 claims description 19
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 17
- 230000001678 irradiating effect Effects 0.000 claims description 17
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 15
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 239000011347 resin Substances 0.000 claims description 11
- 229920005989 resin Polymers 0.000 claims description 11
- 238000009833 condensation Methods 0.000 claims description 7
- 230000005494 condensation Effects 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 5
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 4
- 150000002334 glycols Chemical class 0.000 claims description 4
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 238000010899 nucleation Methods 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 description 232
- 239000010410 layer Substances 0.000 description 103
- 239000000243 solution Substances 0.000 description 45
- 210000001519 tissue Anatomy 0.000 description 45
- 239000011521 glass Substances 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 17
- 230000015556 catabolic process Effects 0.000 description 15
- 238000006731 degradation reaction Methods 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 239000007853 buffer solution Substances 0.000 description 14
- 230000000593 degrading effect Effects 0.000 description 14
- 125000006502 nitrobenzyl group Chemical group 0.000 description 14
- 239000001963 growth medium Substances 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 238000005406 washing Methods 0.000 description 12
- 239000002904 solvent Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 9
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 238000004132 cross linking Methods 0.000 description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000001879 gelation Methods 0.000 description 7
- 239000000017 hydrogel Substances 0.000 description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- 238000010526 radical polymerization reaction Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 230000010261 cell growth Effects 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- -1 poly(4-vinylpyridine) Polymers 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 238000000423 cell based assay Methods 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 4
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 4
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000011247 coating layer Substances 0.000 description 4
- 210000004748 cultured cell Anatomy 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 239000007995 HEPES buffer Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 229920005601 base polymer Polymers 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 239000007857 degradation product Substances 0.000 description 3
- 238000010872 live dead assay kit Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 238000000206 photolithography Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- BGWLYQZDNFIFRX-UHFFFAOYSA-N 5-[3-[2-[3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propylamino]ethylamino]propyl]-6-phenylphenanthridin-5-ium-3,8-diamine;dichloride Chemical compound [Cl-].[Cl-].C=1C(N)=CC=C(C2=CC=C(N)C=C2[N+]=2CCCNCCNCCC[N+]=3C4=CC(N)=CC=C4C4=CC=C(N)C=C4C=3C=3C=CC=CC=3)C=1C=2C1=CC=CC=C1 BGWLYQZDNFIFRX-UHFFFAOYSA-N 0.000 description 2
- 229920002799 BoPET Polymers 0.000 description 2
- 0 CCCC(C)(*(C)*)NN(*)*(CC)=CC Chemical compound CCCC(C)(*(C)*)NN(*)*(CC)=CC 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 241001662443 Phemeranthus parviflorus Species 0.000 description 2
- 206010034972 Photosensitivity reaction Diseases 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 238000000059 patterning Methods 0.000 description 2
- NRNCYVBFPDDJNE-UHFFFAOYSA-N pemoline Chemical compound O1C(N)=NC(=O)C1C1=CC=CC=C1 NRNCYVBFPDDJNE-UHFFFAOYSA-N 0.000 description 2
- 238000001782 photodegradation Methods 0.000 description 2
- 208000007578 phototoxic dermatitis Diseases 0.000 description 2
- 231100000018 phototoxicity Toxicity 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- JWESTWISAMMBBU-UHFFFAOYSA-N 4-[4-[1-(9h-fluoren-9-ylmethoxycarbonylamino)ethyl]-2-methoxy-5-nitrophenoxy]butanoic acid Chemical compound C1=C(OCCCC(O)=O)C(OC)=CC(C(C)NC(=O)OCC2C3=CC=CC=C3C3=CC=CC=C32)=C1[N+]([O-])=O JWESTWISAMMBBU-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 1
- 101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 101710184528 Scaffolding protein Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000012832 cell culture technique Methods 0.000 description 1
- 230000035289 cell-matrix adhesion Effects 0.000 description 1
- 210000003570 cell-matrix junction Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 125000004956 cyclohexylene group Chemical group 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229940116978 human epidermal growth factor Drugs 0.000 description 1
- VWQWXZAWFPZJDA-CGVGKPPMSA-N hydrocortisone succinate Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)COC(=O)CCC(O)=O)[C@@H]4[C@@H]3CCC2=C1 VWQWXZAWFPZJDA-CGVGKPPMSA-N 0.000 description 1
- 229950006240 hydrocortisone succinate Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000002952 image-based readout Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000003738 lymphoid progenitor cell Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000005074 megakaryoblast Anatomy 0.000 description 1
- 210000003593 megakaryocyte Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000003003 monocyte-macrophage precursor cell Anatomy 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 210000002894 multi-fate stem cell Anatomy 0.000 description 1
- 210000001167 myeloblast Anatomy 0.000 description 1
- 210000003643 myeloid progenitor cell Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 210000003924 normoblast Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000075 poly(4-vinylpyridine) Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920013716 polyethylene resin Polymers 0.000 description 1
- 229920000306 polymethylpentene Polymers 0.000 description 1
- 239000011116 polymethylpentene Substances 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002717 polyvinylpyridine Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000025600 response to UV Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000008684 selective degradation Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 210000001988 somatic stem cell Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33379—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing nitro group
- C08G65/33386—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing nitro group cyclic
- C08G65/33389—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing nitro group cyclic aromatic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33331—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group
- C08G65/33337—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group cyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/40—Polyamides containing oxygen in the form of ether groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/20—Material Coatings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/30—Constructional details, e.g. recesses, hinges biodegradable
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2537/00—Supports and/or coatings for cell culture characterised by physical or chemical treatment
- C12N2537/10—Cross-linking
Definitions
- the present invention relates to a photodegradable cross-linking agent, which belongs to the field of material engineering and can be used particularly for manufacturing a complicated three-dimensional microtissue, and to a photodegradable gel, a cell culture instrument, a cell arrangement ⁇ sorting apparatus, a cell arrangement method, a cell sorting method, a tissue forming method, and a tissue which use the photodegradable cross-linking agent.
- NPL 1 Eroom's law
- the surrounding environment of the cell is greatly different from the internal environment of an animal, and this leads to a problem in that the cultured cell loses many of its functions which are supposed to be expressed in the body of the animal.
- next generation cellular assay techniques an assay with higher reliability is adopted which uses a tissue having a higher function by artificially reconstructing a tissue imitating a three-dimensional structure in a biological body. Accordingly, an in vivo-in vitro correlation is expected to become stronger.
- the hydrogel is excellent as a cell carrier (NPL 3).
- the hydrogel By the incorporation of a photodegradable group into the hydrogel molecule, the hydrogel obtains photodegradability, and in this way, a photodegradable gel which can be optically processed is developed.
- a photodegradable gel which has polyethylene glycol as a main chain and contains a nitrobenzyl group in a molecule (PTL 1 and NPL 4).
- the physical properties of the hydrogel formed of a polymer monomer constituted as above can be controlled in terms of time and space by light irradiation (NPL 5 and 6), and the photodegradability is highly compatible with a living cell (NPL 4 and 7).
- the photodegradable gels reported so far are gelated by means of radical polymerization, they deteriorate in some cases by being influenced by oxygen when they are polymerized in the presence of oxygen. Furthermore, a radical damages cells or bioactive substances.
- the polymer compound usable as a main chain is restricted to a polymer of a radically polymerizable monomer, there is a problem that the use thereof is limited.
- the inventors of the present invention have developed a photodegradable cross-linking agent which can form a photodegradable gel by causing a cross-linking reaction simply by being mixed with a polymer compound without using radical polymerization (PTL 2).
- PTL 2 radical polymerization
- Patent Literature (PTL) PTL
- NPL Non-Patent Literature
- the conventional photodegradable gel which can be polymerized without using a radical polymerization reaction, swells by absorbing a solvent and thus collapses. Therefore, an intended structure cannot be constructed in some cases. Furthermore, there are problems in that the strength of the gel is poor, and it is difficult to prepare a complicated three-dimensional structure which can reproduce a biological structure.
- the concentration of the compound constituting the gel may be increased. However, if the concentration is increased, the moisture content of the gel is reduced.
- the present invention has been made in consideration of the circumstances described above, and an object thereof is to provide a photodegradable cross-linking agent capable of manufacturing a photodegradable gel which has appropriate moisture content and water solubility as a cell carrier and has a strength that makes it possible to construct a complicated three-dimensional microstructure.
- Another object of the present invention is to provide a photodegradable gel containing the photodegradable cross-linking agent, a cell culture instrument having the photodegradable gel, a cell arrangement ⁇ sorting apparatus using the cell culture instrument, a cell arrangement method and a cell sorting method using the cell culture instrument, and a tissue and a tissue forming method using the photodegradable gel.
- the present invention is as follows.
- a photodegradable gel can be manufactured which has appropriate moisture content and water solubility as a cell carrier and has a strength that makes it possible to construct a complicated three-dimensional microstructure. Furthermore, a tissue having a complicated three-dimensional microstructure can be formed, and a highly reliable cellular assay system closer to a biological environment can be realized. Therefore, the present invention contributes to the progress of regenerative medical techniques and the development of novel pharmaceutical products.
- the photodegradable cross-linking agent of the present invention is a compound comprising a polyethylene glycol main chain which has 3 or more branched chains and a photodegradable benzyl group which is disposed on the terminus of the polyethylene glycol main chain, in which the benzyl group has an active ester group, which is reactive with an amino group or a hydroxyl group, and one or more nitro groups in a benzene ring of the benzyl group.
- Examples of the photodegradable cross-linking agent include a compound represented by the following Formula (1).
- each of R 1 to R 4 independently represents a hydrogen atom, Z, -O(CH 2 CH 2 O) n -Z, or a linear or branched alkyl group having 1 to 20 carbon atoms.
- Z represents a photodegradable benzyl group.
- the benzyl group has an active ester group, which is reactive with an amino group or a hydroxyl group, and one or more nitro groups in a benzene ring.
- a plurality of A 1 s represents a linking group.
- Each A 1 independently represents a single bond or a linear or branched alkyl group having 1 to 20 carbon atoms.
- R 1 to R 4 at least 3 or more Rs contain Z, and 2 or more Rs represent -O(CH 2 CH 2 O) n -Z.
- the photodegradable cross-linking agent of the present invention has three or more branched chains. Therefore, plenty of cross-linking points are formed (per single molecule of the cross-linking agent) between the active ester group disposed on the terminus of the branched chain and the polymer compound reacting with the active ester group. Consequently, the photodegradable cross-linking agent of the present invention makes it possible to obtain a photodegradable gel having appropriate strength. Furthermore, the photodegradable cross-linking agent of the present invention has a group containing a photodegradable nitrobenzyl group.
- the photodegradable cross-linking agent of the present invention can be applied to optical microfabrication techniques represented by traditional photolithography or a two-photon excitation process which has been used in recent years.
- the photodegradable cross-linking agent of the present invention makes it possible to obtain a photodegradable gel which can be microfabricated by light irradiation.
- the photodegradable cross-linking agent of the present invention is used, it is possible to construct a gel having a complicated three-dimensional microstructure.
- An average repetition number n of ethylene glycol of the branched chains of polyethylene glycol contained in the photodegradable cross-linking agent represented by Formula (1) is within a range of 20 to 500, preferably within a range of 30 to 250, and even more preferably within a range of 40 to 125.
- the repetition number of ethylene glycol is set within the aforementioned range, the solubility of the gel in water can be improved. Therefore, it is easy to handle the gel at the time of manufacturing and using it and to obtain a uniform photodegradable gel.
- Z represents a photodegradable benzyl group.
- the benzyl group has an active ester group, which is reactive with an amino group or a hydroxyl group, and one or more nitro groups in a benzene ring.
- the benzyl group is preferably a group represented by the following Formula (2) or (3).
- the asterisk represents a position where the compound is bonded to an oxygen atom of ethylene glycol.
- R 5 represents hydrogen or a linear or branched alkyl group having 1 to 6 carbon atoms.
- R 5 is more preferably a linear alkyl group having 1 to 6 carbon atoms, and particularly preferably a methyl group.
- R 6 represents a linear or branched alkyl group having 1 to 6 carbon atoms or a linear or branched alkoxy group having 1 to 6 carbon atoms.
- R 6 is more preferably a linear alkoxy group having 1 to 6 carbon atoms, and particularly preferably a methoxy group.
- R 7 represents an active ester group which is reactive with an amino group or a hydroxyl group.
- R 7 is preferably a derivative of N-hydroxysuccinimide, and more preferably a derivative represented by the following Formula (4).
- the asterisk represents a position where the compound is bonded to a carbon atom of a benzene ring.
- q represents an integer of 1 to 10.
- q is preferably 1 to 6, more preferably 2 to 5, and particularly preferably 3.
- the compound represented by Formula (1) is preferably a compound represented by any of the following Formulae (7) and (8).
- n, Z, A 1 , R 1 to R 4 , and p are the same as those in Formula (1).
- the compound represented by Formula (1) is preferably a compound represented by the following Formula (9).
- the compound represented by Formula (9) is preferably a compound represented by the following Formula (10) or (11).
- n and Z are the same as those in Formula (1).
- the compound represented by Formula (1) is preferably a compound represented by the following Formula (12).
- Z is the same as Z in Formula (1).
- p 1 represents an integer of equal to or greater than 1.
- the compound represented by Formula (12) is preferably a compound represented by the following Formula (13) or (14).
- n and Z are the same as those in Formula (1).
- the 4-arm branched or 8-arm branched polyethylene glycol (or a derivative thereof) is easily synthesized and readily available. Therefore, the polyethylene glycol in the compound represented by Formula (1) is preferably 4-arm branched or 8-arm branched (the numbr of the branched chains is 4 or 8).
- the photodegradable cross-linking agent of the present invention is more preferably a compound represented by the following Formula (15) or (16).
- the compound represented by Formula (15) or (16) is more preferably a compound represented by the following Formula (17) or (18).
- the polyethylene glycol preferably has a neopentyl skeleton, and is particularly preferably a compound represented by Formula (17) or (18).
- FIG. 1 is a schematic view of the compound represented by Formula (17).
- a photodegradable cross-linking agent 1 contains a main chain 2 which is composed of branched polyethylene glycol (PEG), a photodegradable nitrobenzyl group-containing group 3 which is disposed on the terminus of the branched main chain 2, and an active ester group 4 which is disposed on the terminus of the nitrobenzyl group-containing group 3.
- the photodegradable cross-linking agent 1 has 4-arm branched polyethylene glycol chains, and the branched chains of polyethylene glycol have a neopentyl skeleton at the center.
- the main chain 2 is polyethylene glycol (PEG), and the nitrobenzyl group-containing group 3 is bonded to the main chain 2 through an amide bond portion 5 (-NHCO-).
- PEG polyethylene glycol
- nitrobenzyl group-containing group 3 is bonded to the main chain 2 through an amide bond portion 5 (-NHCO-).
- the compound represented by Formula (1) is a compound having a polyethylene glycol main chain, which has 3 or more branched chains, and a photodegradable benzyl group which is disposed on the terminus of the branched chains, in which the benzyl group has an active ester group, which is reactive with an amino group or a hydroxyl group, and one or more nitro groups in a benzene ring of the benzyl group.
- a reaction will be described in which the photodegradable benzyl group is disposed on the terminus of the branches, and the active ester group is disposed in the benzyl group.
- R 7a represents an active ester group which is reactive with an amino group or a hydroxyl group.
- a group represented by Formula (1-c) is obtained as below.
- a group represented by Formula (1-a) and a compound represented by Formula (19) in a molar amount that is 1.0 to 2.0 times the molar amount of the compound represented by Formula (1-a) are treated in a solvent for tens of minutes to 24 hours at a temperature of 0°C to 200°C, and the solvent is removed. Then, a compound represented by Formula (1-b) is precipitated and purified.
- the resultant and a compound represented by Formula (20) in a molar amount that is 1.0 to 2.0 times greater than the molar amount of the compound represented by Formula (1-b) are treated in a solvent for tens of minutes to 24 hours at a temperature of 0°C to 200°C in the presence of a catalyst, and from the resultant, the compound (1-c) is isolated.
- the catalyst 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) is preferable.
- the group represented by Formula (1-a) is preferably a compound represented by the following Formula (21).
- n and m are the same as those in Formulae (1) to (3).
- the group represented by Formula (1-c) is preferably a compound represented by the following Formula (22).
- n, B 1 , R 5 , R 6 , and q are the same as those in Formulae (1) to (4).
- the photodegradable gel of the present invention is obtained by reacting the photodegradable cross-linking agent of the present invention with a polymer compound which has a total of 2 or more amino groups or hydroxyl groups in a molecule, in which the amino groups or hydroxyl groups of the polymer compound are cross-linked with the active ester group of the photodegradable cross-linking agent through condensation.
- the polymer compound is preferably at least one kind of compound selected from the group consisting of polyethylene glycol, polyvinyl alcohol, basic polysccharide, a protein, and a derivative of any of these.
- the polymer compound is more preferably branched polyethylene glycol or a derivative thereof.
- the polymer compound is more preferably gelatin as a protein.
- polyethylene glycol is preferable because it seldom interacts with a cell and can dissolve in water.
- the number of branches of the branched polyethylene glycol (or a derivative thereof) is preferably equal to or greater than 3.
- 4-arm branched polyethylene glycol (or a derivative thereof) is preferable because it is readily avaialble.
- polyethylene glycol (or a derivative thereof) has an amino group on the terminus thereof.
- the molecular weight of the polyethylene glycol is preferably within a range of 10,000 to 40,000.
- Collagen as a main component of gelatin is the main component of an extracellular matrix of multicellular organisms (animals). Therefore, collagen is preferable as a scaffolding protein of a cell. Furthermore, collagen is preferable because it promotes the growth and differentiation of a cell in some cases.
- the type of the collagen used is not particularly limited, but it is preferable to use a type A gelatin obtained by treating a raw material derived from cow skin or pig skin with an acid.
- the strength of gelatin is not particularly limited. However, it is preferably 200 Bloom to 400 Bloom and more preferably 250 Bloom to 350 Bloom.
- chitosan As the basic polysaccharide, chitosan is preferable.
- the amino groups or hydroxyl groups of the polymer compound are cross-linked with the active ester group of the photodegradable cross-linking agent through condensation.
- the amino group forms an amide bond with the active ester group of the photodegradable cross-linking agent, and the hydroxyl group forms an ester bond with the active ester group.
- a network structure is formed, gelation proceeds, and a photodegradable gel is generated.
- an additive for accelerating the cross-linking reaction is not particularly required. Accordingly, simply by mixing the polymer compound with the photodegradable gel, the cross-linking reaction occurs, and gelation proceeds. Furthermore, the reaction may be performed at room temperature.
- the cross-linking reaction is not influenced by dissolved oxygen, and hence a thin film-like gel is easily formed.
- the amount of the photodegradable cross-linking agent added to the polymer compound can be freely set within a range in which gelation occurs.
- a molar ratio of the active ester group of the photodegradable cross-linking agent to the amino group of the polymer compound is preferably about 1:1.
- a mixing ratio (polymer compound:photodegradable cross-linking agent) between the polymer compound and the photodegradable cross-linking agent is preferably within a range of 4:1 to 1:4, and more preferably within a range of 2:1 to 1:2.
- the amount thereof used is preferably set such that the amount of the polyethylene glycol contained in the photodegradable gel becomes equal to or greater than 2.5% by weight.
- the amount thereof used is preferably set such that the amount of gelatin contained in the photodegradable gel becomes equal to or greater than 1.0% by weight.
- FIG. 3A is a view showing a reaction in which an active ester group 4 disposed on the terminus of a photodegradable cross-linking agent 1 is cross-linked with an amino group 8 of the polymer compound by forming an amide bond 9 through condensation.
- FIG. 3B is a view schematically showing a reaction in which a photodegradable gel 10 is generated by reacting the photodegradable cross-linking agent with a polymer compound 6.
- the polymer compound 6 is a 4-arm branched polyethylene glycol derivative having the amino group 8 on the terminus.
- the amino group of the polymer compound 6 is cross-linked with the active ester group 4 of the photodegradable cross-linking agent 1 through condensation.
- the polymer compound 6 is bonded to another polymer compound 6 through the photodegradable cross-linking agent 1, and thus the photodegradable gel 10 having a network structure is generated.
- FIG. 3C is a view schematically showing a reaction in which a photodegradable gel 10' is generated by reacting the photodegradable cross-linking agent with a polymer compound 7.
- the polymer compound 7 is gelatin having the amino group 8 in a molecule.
- the polymer compound 7 is bonded to another polymer compound 7 through the photodegradable cross-linking agent 1, and thus the photodegradable gel 10' having a network structure is generated.
- the photodegradable gel of the present invention is degraded by the degradation of the photodegradable cross-linking agent 1 through light irradiation.
- FIG. 4A is a view showing the way a nitrobenzyl group of the photodegradable cross-linking agent is degraded.
- a nitrobenzyl group-containing group 3 can be degraded by being irradiated with light such as ultraviolet rays having a wavelength of 330 nm to 380 nm.
- the nitrobenzyl group-containing group 3 When a bond between the nitrobenzyl group-containing group 3 and an amino group of an amide bond portion 5 is cleaved, the nitrobenzyl group-containing group 3 turns into a nitrobenzyl group 3'.
- a bond between the nitrobenzyl group-containing group 3 and the active ester group 4 is cleaved by the light irradiation described above.
- FIGS. 4B and 4C are views schematically showing the way the photodegradable gels 10 and 10'are degraded by the light irradiation. As a result of the degradation, the photodegradable gel dissolves in water.
- the photodegradable cross-linking agent having the structure described above is used, a cross-linking reaction occurs simply by mixing the photodegradable cross-linking agent with the polymer compound, and thus gelation proceeds.
- the photodegradable cross-linking agent of the present invention is used, the condition of the oxygen-free atmosphere is not required. Accordingly, the manufacturing process of a thin film-like gel is simplified, and it is possible to efficiently prepare a photodegradable gel at low cost.
- a radical polymerization is not used for the cross-linking reaction. Accordingly, it is possible to prepare a photodegradable gel in a state in which substances that are easily damaged by a radical are mixed together. Consequently, the photodegradable gel can be used for various purposes, for example, for the purpose of immobilizing cells or bioactive substances.
- a polymer of a monomer which cannot be subjected to radical polymerization can also be used as a polymer compound. Therefore, the present invention is advantageous because a wide range of polymer compounds can be selected.
- the photodegradable gel of the present invention has appropriate strength and photodegradability. Therefore, the photodegradable gel of the present invention can be applied to optical microfabrication techniques represented by traditional photolithography or a two-photon excitation process which has been used in recent years. Furthermore, the photodegradable gel of the present invention can achieve appropriate moisture content as a cell carrier while having appropriate strength. Accordingly, the photodegradable gel of the present invention is an extremely useful material because it can be used as a cell carrier having a complicated three-dimensional microstructure.
- a layer composed of the photodegradable gel of the present invention is formed on the surface of a cell culture substrate.
- the thickness of the photodegradable gel layer is preferably 100 nm to 100 ⁇ m, more preferably 300 nm to 30 ⁇ m, and particularly preferably 1,000 nm to 10 ⁇ m.
- the material constituting the cell culture substrate is not particularly limited, and examples thereof include plastic, glass, modified glass, a metal, and the like.
- a styrene-based resin for example, polystyrene (PS)), an acrylic resin (for example, a polymethyl methacrylate (PMMA) resin), a polyvinylpyridine-based resin (poly(4-vinylpyridine), a 4-vinylpyridine-styrene copolymer, or the like), a silicone-based resin (for example, a polydimethylsiloxane resin), a polyolefin-based resin (for example, a polyethylene resin, a polypropylene resin, or a polymethylpentene resin), a polyester resin (polyethylene terephthalate (PET) resin), a polycarbonate-based resin, an epoxy resin, and the like are preferable.
- PS polystyrene
- an acrylic resin for example, a polymethyl methacrylate (PMMA) resin
- PMMA polymethyl methacrylate
- a polyvinylpyridine-based resin poly(4-vinylpyridine),
- a substrate is preferable which has the same structure as that of a cell culture dish or a microplate that are generally used for cell culturing.
- At least the surface of the cell culture substrate is composed of polystyrene or a cell-adhesive material.
- cell-adhesive material a cell-adhesive protein or a cell-adhesive peptide is preferable.
- the cell-adhesive protein is preferably at least one kind of protein selected from the group consisting of fibronectin, collagen, gelatin, and laminin, and particularly preferably gelatin.
- the cell-adhesive peptide preferably has an amino acid sequence consisting of arginine-glycine-aspartate (RGD sequence).
- a layer composed of the photodegradable gel of the present invention is formed on the surface of a cell culture substrate.
- the photodegradable gel of the present invention is a material preferable as a cell carrier which can construct a complicated three-dimensional microstructure.
- FIG. 5 shows an example of a cell arrangement ⁇ sorting apparatus of the present invention.
- the apparatus includes a holding stand 12 which holds a cell culture instrument 11 and an irradiation portion 13 which irradiates the cell culture instrument 11 with light.
- the irradiation portion 13 has a light source (not shown in the drawing), an irradiation area-adjusting portion 14 which irradiates only a certain partial area of the cell culture instrument 11 with light, and a control portion 15 such as a personal computer.
- the irradiation area-adjusting portion 14 can irradiate the cell culture instrument 11 with light which forms a predetermined pattern 16.
- the pattern 16 is displayed on a display device 17.
- the irradiation area-adjusting portion 14 includes, for example, a Digital Micromirror Device (DMD).
- DMD has a plurality of micromirrors, and each of the micromirrors is disposed such that the angle thereof can be independently set according to a signal from the control portion 15.
- the micromirrors By reflecting light from the light source, the micromirrors enable the cell culture instrument 11 to be irradiated with light 18 forming a pattern according to the signal.
- the irradiation area-adjusting portion 14 can irradiate a certain area of the cell culture instrument 11 with light 18.
- the irradiation area-adjusting portion 14 can irradiate only a partial area of the cell culture instrument 11 with the light 18 in a certain shape or can irradiate the entire area of the cell culture instrument 11 with the light 18.
- the light source those that can degrade the photodegradable cross-linking agent are selected.
- light sources for example, an ultraviolet lamp and a visible light lamp
- can radiate light such as ultraviolet rays and visible light.
- the wavelength band of the light is, for example, 200 nm to 1,000 nm.
- the wavelength band is preferably 300 nm to 600 nm and particularly preferably 350 nm to 400 nm.
- the irradiation energy is generally 0.01 J/cm 2 to 1,000 J/cm 2 , preferably 0.1 J/cm 2 to 100 J/cm 2 , and more preferably 1 J/cm 2 to 10 J/cm 2 .
- the constituent for irradiating only a partial area of the cell culture substrate with light is not limited to DMD, and it is possible to adopt a liquid crystal shutter array, an optical spatial modulation element, a photomask in a predetermined shape, and the like.
- the cell arrangement ⁇ sorting apparatus shown in FIG. 5 can be used as a cell arrangement apparatus for arranging cells in a partial area irradiated with light and as a sorting apparatus for sorting cells into cells in the area irradiated with light and cells in other areas.
- the photodegradable gel of the present invention is a material which can construct a complicated three-dimensional microstructure by light irradiation and can be used as a cell carrier. Accordingly, if the cell arrangement ⁇ sorting apparatus of the present invention is combined with an optical microfabrication technique and a cell culture technique, cells can be three-dimensionally arranged, cultured, and sorted with high accuracy. Furthermore, because cells can be arranged, cultured, and sorted simultaneously, it is possible to sort and arrange cells while ascertaining the three-dimensional state of the cells.
- a cell sorting method which includes a step of irradiating only a partial area of the cell culture instrument with light by using the cell culture instrument of the present invention so as to selectively degrade the photodegradable gel of the partial area and to sort cells into cells in the partial area and cells in an area other than that (the partial area). Furthermore, a cell arrangement method including a step of arranging cells in the partial area will be described.
- the cells to be sorted are not particularly limited. According to the purpose, it is possible to use cells derived from animals (for example, human cells), cells derived from plants, cells derived from microorganisms, and the like.
- somatic stem cells such as hematopoietic stem cells, myeloid stem cells, neural stem cells, and dermal stem cells; embryonic stem cells; and artificial multipotent stem cells.
- white blood cells such as neutrophils, eosinophils, basophils, monocytes, lymphocytes (T cells, NK cells, B cells, and the like), hemocytes such as thrombocytes, red blood cells, vascular endothelial cells, lymphoid stem cells, erythroblasts, myeloblasts, monoblasts, megakaryoblasts, and megakaryocytes; endothelial cells, epithelial cells, liver parenchymal cells, cells of the islets of Langerhans, and various cell strains established for research purposes can be the target of the present invention.
- hemocytes such as thrombocytes, red blood cells, vascular endothelial cells, lymphoid stem cells, erythroblasts, myeloblasts, monoblasts, megakaryoblasts, and megakaryocytes
- endothelial cells epithelial cells, liver parenchymal cells, cells of the islets of Langerhans, and various cell
- the attachment (adhesion) of a cell means a state in which the cell does not move from its position even when a certain physical stimulus such as washing with a culture medium, a buffer solution, or the like is given to the cell.
- a state in which a cell does not move even when being washed by the flow of a culture medium, a buffer solution, or the like at a predetermined shear stress can be regarded as an "adhesion state" (attachment state).
- the cell arrangement and sorting method of the present invention is a method of selectively degrading the photodegradable gel of a partial area by irradiating only the partial area of the cell culture instrument.
- the photodegradable gel is also processed while being degraded.
- the vertical and horizontal directions (XY-axis direction) of the photodegradable gel layer are focused on, by the selective degradation of the photodegradable gel, the photodegradable gel is two-dimensionally processed.
- the thickness direction (Z-axis direction) of the photodegradable gel layer is focused on, the photodegradable gel is three-dimensionally processed.
- the entirety of the gel may be degraded.
- only the degradation depth in the Z-axis direction can be arbitrarily changed without degrading the entirety of the gel.
- FIG. 6A is a schematic view of a cell culture instrument 30.
- a photodegradable gel layer 32 is formed on the surface of a cell culture substrate 31.
- the surface of the cell culture substrate 31 is preferably a material having low cell adhesiveness, such as glass or a silicone-resin.
- the photodegradable gel layer preferably exhibits high cell adhesiveness, and the polymer compound cross-linked with the photodegradable cross-linking agent of the present invention contained in the photodegradable gel layer is preferably the cell-adhesive protein described above.
- the photodegradable gel layer 32 may be a mixed material in which the photodegradable gel is mixed with the cell-adhesive material.
- An area A1 as a portion of the photodegradable gel layer 32 of the cell culture instrument 30 is irradiated with light through a photomask 35, thereby degrading the photodegradable gel layer 32 of the area A1.
- the photodegradable gel of the area A1 is solubilized and removed from the surface of the cell culture substrate 31 by washing. In this way, the photodegradable gel layer 32 is three-dimensionally processed.
- the cells 34 adhere only to a surface 33 of the photodegradable gel layer 32 and a surface 33' of the photodegradable gel layer that is newly formed by the light irradiation.
- the cells 34 which have not adhered to the surfaces 33 and 33' of the photodegradable gel layer 32 can be removed from the cell culture instrument 30 by being washed with a culture medium, a buffer solution, or the like. In this way, it is possible to selectively arrange the cells 34 on the three-dimensionally processed photodegradable gel layer 32.
- FIG. 6B is a schematic view of a cell culture instrument 40.
- a photodegradable gel layer 42 is formed on the surface of a cell culture substrate 41.
- the surface of the cell culture substrate 41 is preferably a material having high cell adhesiveness, such as polystyrene.
- a coating layer composed of a cell-adhesive material may be formed on the cell culture substrate 41.
- the photodegradable gel layer 42 preferably has low cell adhesiveness.
- the polymer compound cross-linked with the photodegradable cross-linking agent of the present invention contained in the photodegradable gel layer 42 is preferably at least one kind of compound selected from the group consisting of polyethylene glycol, polyvinyl alcohol, basic polysaccharide, a protein having low cell adhesiveness, and a derivative of any of these.
- the polymer compound is particularly preferably a derivative of branched polyethylene glycol.
- the area A1 as a portion of the photodegradable gel layer 42 of the cell culture instrument 40 is irradiated with light through the photomask 35, thereby degrading the photodegradable gel layer 42 of the area A1.
- the photodegradable gel of the area A1 is solubilized and removed from the surface of the cell culture substrate 41 by washing.
- the cells 34 adhere only to the surface of the cell culture substrate 41 of the area A1 from which the photodegradable gel layer 42 has been removed.
- the cells 34 which have not adhered to the surface of the cell culture substrate 41 can be removed from the cell culture instrument 30 by being washed with a culture medium, a buffer solution, or the like. In this way, it is possible to selectively arrange the cells 34 in the area A1.
- FIG. 7A is a schematic view of a cell culture instrument 50.
- the photodegradable gel layer 32 is formed on the surface of a cell culture substrate 51.
- the material of the cell culture substrate 51 is not particularly limited, and the materials described above can be used.
- the photodegradable gel layer 32 preferably has high cell adhesiveness.
- the polymer compound cross-linked with the photodegradable cross-linking agent of the present invention contained in the photodegradable gel layer 32 is preferably the cell-adhesive protein described above.
- the photodegradable gel layer 32 may be a mixed material in which the photodegradable gel is mixed with the cell-adhesive material.
- a coating layer containing the photodegradable gel and the cell-adhesive protein may be formed on the photodegradable gel layer 32.
- the cells 34 adhere onto the surface of the photodegradable gel layer 32.
- the area A1 as a portion of the photodegradable gel layer 32 of the cell culture instrument 50 is irradiated with light through the photomask 35, thereby degrading the photodegradable gel of the area A1.
- the photodegradable gel of the area A1 is solubilized and removed from the surface of the cell culture substrate 51 by washing. In this way, the photodegradable gel layer 32 is three-dimensionally processed. Furthermore, the cells 34 which have adhered to the photodegradable gel of the area A1 are exfoliated from the cell culture substrate 51.
- the exfoliated cells 34 can be selectively removed from the cell culture instrument 50.
- the cells can be sorted into the cells 34 of the area A1 and other cells 34.
- FIG. 7B is a schematic view of a cell culture instrument 60.
- a photodegradable gel layer 62 in which the cells 34 are embedded is formed on the surface of the cell culture substrate 51.
- the material of the cell culture substrate 51 is not particularly limited, and the material described above can be used.
- the polymer compound cross-linked with the photodegradable cross-linking agent of the present invention contained in the photodegradable gel layer 62 is not particularly limited as long as it is a polymer compound having a total of two or more amino groups or hydroxyl groups in a molecule.
- the polymer compound is preferably at least one kind of compound selected from the group consisting of polyethylene glycol, polyvinyl alcohol, basic polysaccharide, a protein, and a derivative of any of these, and more preferably a derivative of branched polyethylene glycol or gelatin.
- the area A1 as a portion of the photodegradable gel layer 62 of the cell culture instrument 60 is irradiated with light through the photomask 35, thereby degrading the photodegradable gel of the area A1.
- the photodegradable gel of the area A1 is solubilized and removed from the surface of the cell culture substrate 51 by washing. In this way, the photodegradable gel layer 62 is three-dimensionally processed. Furthermore, the cells 34 embedded in the photodegradable gel of the area A1 are exfoliated from the cell culture substrate 51.
- the exfoliated cells 34 can be selectively removed from the cell culture instrument 60.
- the cells can be sorted into the cells 34 of the area A1 and other cells 34.
- the cell arrangement method and the cell sorting method described above because only the area A1 of the cell culture instrument 11 is irradiated with light, the negative influence exerted on the cells 34 by the light irradiation can be suppressed as much as possible. Consequently, it is possible to prevent the damage of the extracellular matrix or the membrane protein of the cells 34 and to maintain the organ-specific functions thereof. Therefore, the cell arrangement method and the cell sorting method of the present invention are useful in the fields of cell engineering, regenerative medical techniques, bio-industries tissue-engineering, and the like.
- the cells 34 are sorted by irradiating only the area A1 with light, target cells can be sorted out with high accuracy.
- the photodegradable gel of the present invention is a material preferable as a cell carrier which can construct a complicated three-dimensional microstructure. Therefore, according to the cell arrangement method and the cell sorting method of the present invention, it is possible to three-dimensionally arrange and sort cells with high accuracy.
- the tissue of the present invention refers to a three-dimensional assembly of cells, and may contain the photodegradable gel of the present invention between the cells. It is preferable that the cells are cultured for a certain period of time, to grow, form an intended tissue, and be differentiated into an intended state, by using the photodegradable gel of the present invention.
- the tissue forming method of the present invention includes a step of forming a photodegradable gel.
- the thickness of the photodegradable gel is preferably equal to or greater than 10 ⁇ m which makes it possible for the cells embedded in the gel to be arranged by at least two or more cells in the Z-axis direction and makes it possible to form a three-dimensional tissue. More specifically, the thickness of the photodegradable gel is preferably 20 ⁇ m to 1,000 ⁇ m, and more preferably 50 ⁇ m to 300 ⁇ m.
- the photodegradable gel is irradiated with light. In this way, the photodegradable gel can be partially or entirely degraded, and at least a portion of the photodegradable gel can be removed from the tissue.
- the tissue forming method of the present invention only needs to use the photodegradable gel of the present invention, and may be performed without using the cell culture instrument of the present invention.
- steps (I) to (IV) may be appropriately switched. Alternatively, any of the steps may be performed two or more times.
- FIG. 8A is a schematic view of the cell culture instrument 30.
- the cell culture substrate 31 and the photodegradable gel layer 32 can use the same constitution as in the first exemplary cell arrangement method.
- the area A1 as a portion of the photodegradable gel layer 32 of the cell culture instrument 30 is irradiated with light through the photomask 35, thereby degrading the photodegradable gel layer 32 of the area A1.
- the photodegradable gel of the area A1 is solubilized and removed from the surface of the cell culture substrate 31 by washing. In this way, the photodegradable gel layer 32 is three-dimensionally processed and shaped according to the pattern of the photomask.
- the cells 34 adhere only to the surface 33 of the photodegradable gel layer 32 and the surface 33' of the photodegradable gel layer that is newly formed by the light irradiation.
- the cells 34 which have not adhered to the surfaces 33 and 33' of the photodegradable gel layer 32 can be removed from the cell culture instrument 30 by being washed with a culture medium, a buffer solution, or the like. In this way, it is possible to selectively arrange the cells 34 on the three-dimensionally processed photodegradable gel layer 32.
- the cells 34 can grow by using the processed photodegradable gel layer 32 as a scaffold, and a tissue can be three-dimensionally formed on the cell culture instrument 30.
- FIG. 8B is a schematic view of the cell culture instrument 40.
- the photodegradable gel layer 42 is formed on the surface of the cell culture substrate 41.
- the cell culture substrate 41 and the photodegradable gel layer 42 can use the same constitution as in the second exemplary cell arrangement method.
- the cells those growing without depending on cell-matrix adhesion are preferable, and examples thereof include tumor cells, hematopoietic cells, various stem cells, and the like.
- the area A1 as a portion of the photodegradable gel layer 42 of the cell culture instrument 40 is irradiated with light through the photomask 35, thereby degrading the photodegradable gel layer 42 of the area A1.
- the photodegradable gel of the area A1 is solubilized and removed from the surface of the cell culture substrate 41 by washing. In this way, the photodegradable gel layer 42 is three-dimensionally processed.
- the cells 34 adhere only to the surface of the cell culture substrate 41 of the area A1 from which the photodegradable gel layer 42 has been removed.
- the cells 34 which have not adhered to the surface of the cell culture substrate 41 can be removed from the cell culture instrument 30 by being washed with a culture medium, a buffer solution, or the like. In this way, it is possible to selectively arrange the cells 34 in the area A1.
- the cells 34 can grow in a specified shape in the processed photodegradable gel layer 42, and a tissue can be three-dimensionally formed on the cell culture instrument 40.
- FIG. 8C is a schematic view of the cell culture instrument 50.
- the photodegradable gel layer 32 is formed on the surface of the cell culture substrate 51.
- the cell culture substrate 51 and the photodegradable gel layer 32 can use the same constitution as in the first exemplary cell sorting method. In this case, it is inappropriate to form a coating layer containing a photodegradable gel and a cell-adhesive protein on the photodegradable gel layer 32.
- the cells 34 adhere to the surface of the photodegradable gel layer 32.
- the area A1 as a portion of the photodegradable gel layer 32 of the cell culture instrument 50 is irradiated with light through the photomask 35, thereby degrading the photodegradable gel of the area A1.
- the photodegradable gel of the area A1 is solubilized and removed from the surface of the cell culture substrate 51 by washing. In this way, the photodegradable gel layer 32 is three-dimensionally processed. Furthermore, the cells 34 having adhered to the photodegradable gel of the area A1 are exfoliated from the surface of the cell culture substrate 51.
- the exfoliated cells 34 can be selectively removed from the cell culture instrument 50.
- the cells are sorted into the cells 34 of the area A1 and other cells 34.
- the cells 34 can grow by using the processed photodegradable gel layer 32 as a scaffold, and a tissue can be three-dimensionally formed on the cell culture instrument 50.
- FIG. 8D is a schematic view of the cell culture instrument 50.
- the photodegradable gel layer 32 is formed on the surface of the cell culture substrate 51.
- the cell culture substrate 51 and the photodegradable gel layer 32 can use the same constitution as in the first exemplary cell sorting method. In this case, it is inappropriate to form a coating layer containing a photodegradable gel and a cell-adhesive protein on the photodegradable gel layer 32.
- the cells 34 adhere to the surface of the photodegradable gel layer 32.
- a cell layer can be formed on the cell culture instrument 50.
- the area A1 as a portion of the photodegradable gel layer 32 of the cell culture instrument 50 is irradiated with light through the photomask 35, thereby degrading the photodegradable gel of the area A1.
- the photodegradable gel of the area A1 is solubilized and removed from the surface of the cell culture substrate 51 by washing. In this way, the photodegradable gel layer 32 can be three-dimensionally processed.
- the cells 34 having adhered to the photodegradable gel of the area A1 are exfoliated from the surface of the cell culture substrate 51.
- the exfoliated cells 34 can be selectively removed from the cell culture instrument 50.
- the cells 34 can grow by using the processed photodegradable gel layer 32 as a scaffold, and a tissue can be three-dimensionally formed on the cell culture instrument 50.
- steps (I) to (III) can be appropriately switched. Alternatively, any of the steps may be performed two or more times.
- the cell culture substrate 51 and the photodegradable gel layer 62 can use the same constitution as in the second exemplary cell sorting method.
- FIG. 9A is a schematic view of the cell culture instrument 60.
- the photodegradable gel layer 62 in which the cells 34 are embedded is formed on the surface of the cell culture substrate 51.
- the area A1 as a portion of the photodegradable gel layer 62 of the cell culture instrument 60 is irradiated with light through the photomask 35, thereby degrading the photodegradable gel of the area A1.
- the photodegradable gel of the area A1 is solubilized and removed from the surface of the cell culture substrate 51 by washing. In this way, the photodegradable gel layer 62 is three-dimensionally processed. Furthermore, the cells 34 embedded in the photodegradable gel of the area A1 are exfoliated from the surface of the cell culture substrate 51.
- the exfoliated cells 34 can be selectively removed from the cell culture instrument 60.
- the cells are sorted into the cells 34 of the area A1 and other cells 34.
- the cells 34 can grow in a specified shape within the processed photodegradable gel layer 62, and a tissue can be three-dimensionally formed on the cell culture instrument 60.
- FIG. 9B is a schematic view of the cell culture instrument 60.
- the photodegradable gel layer 62 in which the cells 34 are embedded is formed on the surface of the cell culture substrate 51.
- a lump of cells can be three-dimensionally formed on the cell culture instrument 60.
- the area A1 as a portion of the photodegradable gel layer 62 of the cell culture instrument 60 is irradiated with light through the photomask 35, thereby degrading the photodegradable gel of the area A1.
- the photodegradable gel of the area A1 is solubilized and removed from the surface of the cell culture substrate 51 by washing. In this way, the photodegradable gel layer 62 is three-dimensionally processed. Furthermore, the cells 34 embedded in the photodegradable gel of the area A1 are exfoliated from the surface of the cell culture substrate 51.
- the exfoliated cells 34 can be selectively removed from the cell culture instrument 60.
- the cells can be sorted into the cells 34 of the area A1 and other cells 34, and cells can be removed from the lump of cells that is three-dimensionally formed on the cell culture instrument 60. Thereafter, by culturing, the cells 34 can grow in a specified shape in the processed photodegradable gel layer 62, and a tissue can be three-dimensionally formed on the cell culture instrument 60.
- FIG. 9C is a schematic view of the cell culture instrument 60.
- the photodegradable gel layer 62 in which the cells 34 are embedded is formed on the surface of the cell culture substrate 51.
- the area A1 as a portion of the photodegradable gel layer 62 of the cell culture instrument 60 is irradiated with light through the photomask 35, thereby degrading the photodegradable gel of the area A1.
- the photodegradable gel of the area A1 is solubilized and removed from the surface of the cell culture substrate 51 by washing. In this way, the photodegradable gel layer 62 is three-dimensionally processed. Furthermore, the cells 34 embedded in the photodegradable gel of the area A1 are exfoliated from the surface of the cell culture substrate 51.
- the exfoliated cells 34 can be selectively removed from the cell culture instrument 60.
- the cells can be sorted into the cells 34 of the area A1 and other cells 34.
- a photodegradable gel layer 72 in which a different type of cells 34' from the cells 34 are embedded may be additionally formed on the cell culture substrate 51 or the photodegradable gel layer 62 exposed to light by the light irradiation.
- the photodegradable gel layers 62 and 72 can be processed again by, for example, irradiating an area B1, which is different from the area A1, with light through the photomask 35.
- the cells 34 and 34' can grow in a specified shape in the processed photodegradable gel layers 62 and 72, and a tissue can be three-dimensionally formed on the cell culture instrument 60.
- the photodegradable gel of the present invention is a material preferable as a cell carrier which can construct a complicated three-dimensional microstructure. Therefore, according to the tissue forming method of the present invention, it is possible to form a tissue having a complicated three-dimensional microstructure. Furthermore, a highly reliable cellular assay system closer to the biological environment can be realized.
- the method for synthesizing a photodegradable cross-linking agent (NHS-PD-4arm PEG) is as follows.
- a tetrahydrofuran (THF) solution of SUNBRIGHT PTE-100 HS manufactured by NOF CORPORATION, 9.6 g was added, and the resultant was stirred for tens of minutes to 24 hours under a reflux condition at room temperature.
- THF tetrahydrofuran
- the residue was slowly added dropwise to cooled ether.
- the resultant was left to stand for several hours to 3 days, and then the precipitate was collected by filtration.
- a small amount of the precipitate was dissolved in THF and then slowly added dropwise to cooled ether. The resultant was left to stand for 1 hour to 24 hours, and then the precipitate was collected by filtration (repeated twice).
- the gelatin and the solvent were stirred and mixed together at a temperature of 37°C, thereby obtaining a gelatin solution.
- gelatin solution and the photodegradable cross-linking agent were mixed together in an equal amount, thereby obtaining a gelatin-based photodegradable gel solution.
- the amino-4arm PEG solution and the photodegradable cross-linking agent were mixed together in an equal amount, thereby obtaining a polyethylene glycol-based photodegradable gel solution.
- Amino-coated slide glass (MAS-coated slide glass, manufactured by Matsunami Glass Ind., Ltd.) was coated with the gelatin-based photodegradable gel solution (10 ⁇ L to 30 ⁇ L) of Example 2. Thereafter, the slide glass was covered with another slide glass, thereby forming a photodegradable gel layer.
- the thickness of the gel layer was regulated by the slide glass (thickness: 150 ⁇ m) or a PET film (thickness: 25 ⁇ m).
- a mask for photolithography was prepared by printing a pattern on a film at a resolution of 300 dpi.
- the mask was disposed between an irradiation apparatus and the slide glass.
- the gel is photodegraded by being selectively exposed to light.
- the gel was irradiated with light at an irradiation energy of 7.2 J/cm 2 to 9.0 J/cm 2 until the gel was degraded in the form of an intended pattern.
- As a light source the one having a wavelength of 350 nm to 385 nm and an intensity of 30 mW/cm 2 was used.
- the gel degraded by the light irradiation was washed off in distilled water.
- FIG. 11 is a picture of the gelatin-based photodegradable gel of the present invention that is patternwisely degraded by the light irradiation. It was confirmed that by selectively irradiating the area A1 with light, the gelatin-based photodegradable gel of the present invention can be degraded up to a diameter of 20 ⁇ m with high degradability (XY-plane).
- Amino-coated slide glass (MAS-coated slide glass, manufactured by Matsunami Glass Ind., Ltd.) was coated with the polyethylene glycol-based photodegradable gel solution (10 uL to 30 ⁇ L) of Example 3. Thereafter, the slide glass was covered with another slide glass, thereby forming a photodegradable gel layer.
- the thickness of the gel layer was regulated by using the slide glass (thickness: 150 ⁇ m) or a PET film (thickness: 25 ⁇ m).
- Example 4 In the same manner as in Example 4, a mask was prepared, and the gel was photodegraded.
- FIG. 12 is a picture of the polyethylene glycol-based photodegradable gel of the present invention that is patternwisely degraded by the light irradiation. It was confirmed that by irradiating the area A1 with light, the polyethylene glycol-based photodegradable gel of the present invention can be degraded up to a diameter of 20 ⁇ m with high degradability (XY-plane).
- FIG. 13A is an image showing the state of a gel degraded by light by means of irradiating the area A1 with light at an irradiation energy of 1.5 J/cm 2 .
- Fig. 13B is an image showing the state of a gel degraded by light by means of irradiating the area A1 with light at an irradiation energy of 9.0 J/cm 2 .
- the results obtained by observing the gel surface by using an optical microscope are shown in the upper panels of FIGS. 13A and 13B .
- Fluorescent beads were localized within the patternwisely degraded gel surface, and by using a confocal laser microscope, the degradation shape and degradation depth of the gel were measured.
- the image data obtained by the confocal laser microscope are shown in the middle and lower panels of FIG. 13A and in the middle and lower panels of FIG. 13B .
- the plan views taken along the Z-axis in the position of the broken lines (i), (ii), and (iii) in the middle panels of FIGS. 13A and 13B correspond to (i), (ii), and (iii) of the lower panels of FIGS. 13A and 13B respectively.
- the stronger the irradiation energy the greater the degradation depth in the Z-axis direction within the area A1.
- the gel layer was degraded to a depth of 216 ⁇ m inside the gel.
- the photodegradable gels of Examples 4 and 5 of the present invention can be microfabricated by the light irradiation in any of the directions of X, Y, and Z axes.
- the cells 34 (mouse fibroblasts: NIH-3T3) were added to the amino-4arm PEG solution of Example 3, and the photodegradable cross-linking agent solution was added thereto in the same manner as in Example 3, thereby obtaining a photodegradable gel solution containing the cells 34. Thereafter, the gel layer 62 in which the cells 34 were embedded was formed on slide glass, and the gel was patternwisely degraded by irradiating the area A1 with light. The formation of the gel layer and the patternwise degradation of the gel were performed in the same manner as in Example 4.
- the gel layer 62 in which the cells 34 were embedded and which had been irradiated with light, was stained by using a LIVE/DEAD assay kit (using 0.5 ⁇ L ethidium homodimer-1 and 2.0 ⁇ L of calcein AM (manufactured by Molecular Probes)) so as to check whether the cells 34 were dead or alive.
- FIGS. 14A to 14C show the form of the stained cells.
- FIG. 14A is a fluorescence observation image of the gel layer 62 having not yet been irradiated with light.
- FIG. 14B is an image obtained by observing the gel layer 62, which is patterned after being irradiated with light, in a bright field.
- FIG. 14C is a fluorescence observation image of FIG. 14B .
- 70% or more of the cells 34 embedded in the gel layer gave off a green fluorescence. Therefore, it was revealed that even after the cells 34 are embedded into the photodegradable gel of the present invention, and the gel is patterned by the light irradiation, the cells 34 can survive in an excellent state.
- the photodegradable gel of the present invention using the photodegradable cross-linking agent of the present invention can form a three-dimensional microstructure while keeping cells alive in the gel. Accordingly, the photodegradable gel of the present invention using the photodegradable cross-linking agent of the present invention is an extremely useful tissue engineering material which is suited for forming a complicated three-dimensional microstructure.
- a synthesized NHS-PC-4arm PEG cross-linking agent (10 mM, 12.1% w/w) was mixed with a 10 mM phthalate buffer solution (pH 4.0, manufactured by Wako Pure Chemical Industries, Ltd.), thereby preparing a cross-linking agent solution.
- the prepared cross-linking agent solution was adjusted to become 140 mM NaCl (manufactured by Wako Pure Chemical Industries, Ltd.).
- the gelatin solution was prepared at a temperature of 37°C, and other solutions were prepared at room temperature.
- the prepared base polymer solution and the cross-linking agent solution were mixed together in an equal amount.
- Amino-coated slide glass (MAS coating, manufactured by Matsunami Glass Ind., Ltd.) was coated with the solution mixture of the photodegradable gel solution and the cross-linking agent in a liquid amount of 10 ⁇ L to 30 ⁇ L, and then the slide glass was covered with another slide glass, thereby forming a photodegradable gel layer.
- the thickness of the gel layer was regulated by using a polyethylene terephthalate (PET) film (thickness: 25 ⁇ m) or the cover glass (thickness: 150 ⁇ m).
- PET polyethylene terephthalate
- human umbilical vein endothelial cells (HUVEC) were seeded onto the synthesized gel substrate.
- the photodegradable gel prepared by using amino-4arm PEG or gelatin as a base polymer was used.
- HUVEC were cultured in an environment of 5% CO 2 and a temperature of 37°C, by using HuMedia EG-2 culture solution (manufactured by KURABO INDUSTRIES LTD.) (containing 2% (v/v) fetal bovine serum, 10 ng/mL of a human epidermal growth factor, 1.34 ⁇ g/L of hydrocortisone hemisuccinate, 50 ⁇ g/mL of gentamicin, 50 ng/mL of amphotericin B, 5 ng/mL of a human basic fibroblast growth factor, and 10 ⁇ g/mL of heparin).
- HuMedia EG-2 culture solution manufactured by KURABO INDUSTRIES LTD.
- fetal bovine serum 10 ng/mL of a human epidermal growth factor
- 1.34 ⁇ g/L of hydrocortisone hemisuccinate 50 ⁇ g/mL of gentamicin
- 50 ng/mL of amphotericin B 5
- the cultured cells were exposed for 5 minutes to a DPBS solution containing 0.1% trypsin, and the cells were recovered. Then, by using HuMedia EG-2 culture solution, a cell suspension having a final cell concentration of 1.0 ⁇ 10 7 cells/mL was prepared.
- the HUVEC were seeded onto the photodegradable gel prepared by using amino-4arm PEG or gelatin.
- the cells were seeded onto the photodegradable gel, spread over the entire surface of the gel, and then left to stand in the culture instrument.
- the cells which had not adhered to the surface of the photodegradable gel and the excess culture solution were removed by being aspirated into a pipette, and 3 mL of the culture solution was added to a 35 mm 2 culture plate and left to stand again in the culture instrument.
- the images of the cells were observed under an inverted microscope. Furthermore, in order to determine whether the cells were dead or alive on day 3 after culturing, the cells were stained by using a LIVE/DEAD assay kit (0.5 ⁇ L of ethidium homodimer 1, 2.0 ⁇ L of calcein AM (manufactured by Molecular probes)). The cultured cells were stained with the cell staining solution for 10 minutes and washed with DPBS. Thereafter, a bright field image and a fluorescence image of the cells were observed under an inverted microscope.
- a LIVE/DEAD assay kit 0.5 ⁇ L of ethidium homodimer 1, 2.0 ⁇ L of calcein AM (manufactured by Molecular probes)
- the gel was patternwisely irradiated with light (365 nm, 125 mW/cm 2 , 8 seconds to 24 seconds), and the cells were cultured 3 more hours at a temperature of 37°C, thereby performing a test in which the cells were exposed to the degradation product of the gel.
- the sample was irradiated with light by using a PC-controlled micro-projection system (DESM-01, manufactured by Engineering System Co.) (see NPL 8).
- HUVEC in order to evaluate the behavior of cells on the photodegradable gel, HUVEC were cultured as model cells. As a result, HUVEC substantially did not adhere onto the surface of the photodegradable gel prepared by using amino-4arm PEG ( FIG 15 ). Presumably, this is because PEG is a non-cell-adhesive substrate (see NPL 9). In contrast, it was revealed that all of HUVEC adhere onto the surface of gel prepared by using gelatin ( FIGS. 16A and 16B ).
- the result of the present study implies that the behavior of cells (adhesion of cells onto a substrate, cell elongation on a substrate, and cell growth on a substrate) on a synthesized photodegradable gel is likely to vary with the concentration of the photodegradable cross-linking agent.
- HUVEC cultured on the same photodegradable gel as in Example 8 was irradiated with light (1.0 J/cm 2 to 3.0 J/cm 2 ) through a photomask. Furthermore, in order to evaluate the phototoxicity at the time of light irradiation and to evaluate the cytotoxicity of the degradation product of gel, whether the cells were dead or alive was determined by using a LIVE/DEAD assay kit.
- FIGS. 18C and 18D The pattern of the cells shown in the drawings was formed as a result of the photodegradation of the gel, and this implied that the cells on the gel are likely to be able to be controlled in a micro-order.
- the cells elongated on the gel were irradiated with light, and then whether the cells were dead or alive was determined. As a result, it was confirmed that there is no big difference in the cell survival/death rate between the cells in the region irradiated with light and the cells in the region not irradiated with light ( FIGS. 18B to 18D ). That is, it was revealed that the survival of cells is not influenced by the light irradiation and the gel degradation.
- a photodegradable gel can be prepared from amino-4arm PEG and gelatin, and a photodegradable hydrogel can be prepared by using a biomolecule having an amino portion as it is. Furthermore, because the photodegradable cross-linking agent described in the present application is considered to be able to react with other naturally occurring polymers (collagen, fibronectin, chitosan, and the like), a possibility of preparing various photodegradable hydrogels is increased.
- the present invention is useful in the fields of cell engineering, regenerative medical techniques, bio-industries, tissue-engineering, and the like.
- 1 ⁇ photodegradable cross-linking agent 1 ⁇ photodegradable cross-linking agent, 2 ⁇ main chain, 3 ⁇ nitrobenzyl group-containing group, 4 ⁇ active ester group, 5 ⁇ amide bond portion, 6 ⁇ polymer compound, 7 ⁇ polymer compound, 8 ⁇ amino group, 9 ⁇ amide bond between cross-linking agent and polymer compound, 10 ⁇ photodegradable gel, 11 ⁇ 30 ⁇ 40 ⁇ 50 ⁇ 60 ⁇ cell culture instrument, 31 ⁇ 41 ⁇ 51 ⁇ cell culture substrate, 32 ⁇ 42 ⁇ 62 ⁇ 72 ⁇ photodegradable gel layer, 33 ⁇ surface of photodegradable gel layer, 34 ⁇ cell, 35 ⁇ photomask, A1 ⁇ B1 ⁇ partial area irradiated with light
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Clinical Laboratory Science (AREA)
- Biodiversity & Conservation Biology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Polyamides (AREA)
- Polyethers (AREA)
- Polyesters Or Polycarbonates (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Claims (17)
- Agent de réticulation photodégradable comprenant :une chaîne principale de polyéthylène glycol qui comporte trois ou plus de trois chaînes ramifiées ; etun groupe benzyle photodégradable qui est disposé sur la terminaison de la chaîne principale de polyéthylène glycol comportant les chaînes ramifiées,dans lequel le groupe benzyle comporte un groupe ester actif, qui est réactif avec un groupe amino ou un groupe hydroxyle, et un ou plusieurs groupes nitro dans un cycle benzénique du groupe benzyle.
- Agent de réticulation photodégradable selon la revendication 1,
dans lequel le groupe ester actif est un dérivé de N-hydroxysuccinimide. - Agent de réticulation photodégradable selon la revendication 1 ou 2,
dans lequel le nombre moyen de répétitions d'éthylène glycol dans les chaînes ramifiées est dans une plage de 20 à 500. - Agent de réticulation photodégradable selon l'une quelconque des revendications 1 à 3,
dans lequel le nombre des chaînes ramifiées est 4 ou 8. - Agent de réticulation photodégradable selon l'une quelconque des revendications 1 à 4,
dans lequel la chaîne principale de polyéthylène glycol a un squelette de néopentyle. - Gel photodégradable caractérisé en ce qu'il est obtenu par réaction de l'agent de réticulation photodégradable selon l'une quelconque des revendications 1 à 5 avec un composé polymère ayant un total de deux ou plus de deux groupes amino ou groupes hydroxyle dans une molécule,
dans lequel les groupes amino ou les groupes hydroxyle dans le composé polymère sont réticulés avec le groupe ester actif de l'agent de réticulation photodégradable par condensation, de façon à former une liaison amide ou une liaison ester. - Gel photodégradable selon la revendication 6, dans lequel le composé polymère est au moins un type de composé choisi dans le groupe constitué d'un polyéthylène glycol, d'un alcool polyvinylique, d'un polysaccharide basique, d'une protéine, et d'un dérivé de l'un quelconque de ceux-ci.
- Gel photodégradable selon la revendication 6 ou 7,
dans lequel le composé polymère est un dérivé de polyéthylène glycol ramifié. - Gel photodégradable selon la revendication 6 ou 7,
dans lequel le composé polymère est la gélatine. - Instrument de culture de cellules,
dans lequel une couche composée du gel photodégradable selon l'une quelconque des revendications 6 à 9 est formée sur la surface d'un substrat de culture de cellules. - Instrument de culture de cellules selon la revendication 10,
dans lequel au moins la surface du substrat de culture de cellules est composé d'une résine de styrène ou d'un matériau d'adhésion cellulaire. - Appareil de tri d'agencement de cellules comprenant :l'instrument de culture de cellules selon la revendication 10 ou 11 ; etune partie d'irradiation portion irradiant l'instrument de culture de cellules avec de la lumière,dans lequel la partie d'irradiation comporte une source de lumière et une partie d'ajustement de zone d'irradiation qui irradie uniquement une certaine zone partielle de la surface de l'instrument de culture de cellules avec la lumière provenant de la source de lumière.
- Procédé de tri de cellules comprenant :
une étape d'irradiation de seulement une zone partielle de l'instrument de culture de cellules selon la revendication 10 ou 11 avec de la lumière de façon à dégrader sélectivement le gel photodégradable de la zone partielle et trier en cellules de la zone partielle et en cellules dans une zone autre que la zone partielle. - Procédé d'agencement de cellules comprenant :
une étape d'irradiation de seulement une zone partielle de l'instrument de culture de cellules selon la revendication 10 ou 11 avec de la lumière de façon à dégrader sélectivement le gel photodégradable de la zone partielle et agencer les cellules dans la zone partielle. - Procédé de formation de tissu comprenant :(I) une étape de formation du gel photodégradable selon la revendication 6 ;(II) une étape de spécification de la forme du gel photodégradable par irradiation de lumière ;(III) une étape d'ensemencement de cellules dans le gel photodégradable ; et(IV) une étape de culture des cellules.
- Procédé de formation de tissu comprenant :(I) une étape de formation du gel photodégradable selon la revendication 6 par incorporation de cellules dans le gel photodégradable ;(II) une étape de spécification de la structure du gel photodégradable par irradiation de lumière ; et(III) une étape de culture de cellules.
- Tissu comprenant :le gel photodégradable selon l'une quelconque des revendications 6 à 9 ; etdes cellules.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013108429 | 2013-05-22 | ||
PCT/JP2014/062725 WO2014188911A1 (fr) | 2013-05-22 | 2014-05-13 | Agent de réticulation photodégradable, gel photodégradable, dispositif de culture cellulaire, dispositif d'agencement/séparation de cellules, procédé d'agencement de cellules, procédé de séparation de cellules, procédé de formation de matériel tissulaire, et matériel tissulaire |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3000836A1 EP3000836A1 (fr) | 2016-03-30 |
EP3000836A4 EP3000836A4 (fr) | 2016-05-18 |
EP3000836B1 true EP3000836B1 (fr) | 2018-12-26 |
Family
ID=51933472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14801820.3A Not-in-force EP3000836B1 (fr) | 2013-05-22 | 2014-05-13 | Agent de réticulation photodégradable |
Country Status (4)
Country | Link |
---|---|
US (1) | US9908972B2 (fr) |
EP (1) | EP3000836B1 (fr) |
JP (1) | JP6056111B2 (fr) |
WO (1) | WO2014188911A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016158327A1 (fr) * | 2015-03-30 | 2016-10-06 | 国立大学法人 東京大学 | Composé pour fixer une composition contenant une membrane lipidique, matériau de base modifié par le composé, procédé de formation de motifs de la composition contenant une membrane lipidique sur le matériau de base et procédé pour isoler la composition contenant une membrane lipidique sur le matériau de base |
WO2016159380A1 (fr) * | 2015-04-03 | 2016-10-06 | 国立研究開発法人産業技術総合研究所 | Hydrogel photodégradable, dispositif de culture, procédé de formation d'un corps organique et procédé de séparation de cellules |
JP2019090610A (ja) * | 2016-03-25 | 2019-06-13 | 国立研究開発法人科学技術振興機構 | セルソーティング方法、並びにこれを利用したフローサイトメトリー及びセルソーター |
JP2018027029A (ja) * | 2016-08-16 | 2018-02-22 | 学校法人 関西大学 | 細胞シート作製装置 |
JP6721881B2 (ja) * | 2017-02-23 | 2020-07-15 | 日本電信電話株式会社 | 細胞足場材料、細胞モデル、及び細胞足場材料の製造方法 |
CN109776450B (zh) * | 2017-11-15 | 2021-03-19 | 中山光禾医疗科技有限公司 | 光偶合协同交联水凝胶材料的制备、原料、产品及应用 |
FR3083239B1 (fr) * | 2018-06-27 | 2021-01-15 | Alveole | Methode generique pour la structuration d'hydrogels |
EP4274907A1 (fr) | 2021-01-08 | 2023-11-15 | Cellanome, Inc. | Dispositifs et procédés pour analyser des échantillons biologiques |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU519567B2 (en) * | 1977-07-13 | 1981-12-10 | Akzo Nv | Psychopharmacological penta and hexa-peptides |
JP3199405B2 (ja) * | 1991-08-30 | 2001-08-20 | 生化学工業株式会社 | 肝細胞球状集塊化剤及び球状集塊化肝細胞の製造方法 |
US5980861A (en) * | 1996-03-12 | 1999-11-09 | University Of Massachusetts | Chelator compositions and methods of synthesis thereof |
US6566406B1 (en) * | 1998-12-04 | 2003-05-20 | Incept, Llc | Biocompatible crosslinked polymers |
US7291673B2 (en) * | 2000-06-02 | 2007-11-06 | Eidgenossiche Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
JP4440888B2 (ja) * | 2003-11-04 | 2010-03-24 | スプラポリックス・ビー.ブイ. | 重合体幹内に4重水素結合単位を含む超分子重合体の製造 |
JP4572408B2 (ja) | 2005-10-14 | 2010-11-04 | 独立行政法人産業技術総合研究所 | 光応答性ゲル材料、マイクロバルブおよびマイクロチップ |
US20070190036A1 (en) * | 2006-01-04 | 2007-08-16 | Seda Kizilel | Microencapsulation of pancreatic islets within a thin coat of glucagon-like peptide-1 functionalized poly(ethylene glycol) |
US7960498B2 (en) | 2006-06-30 | 2011-06-14 | Actamax Surgical Materials, Llc | Tissue adhesives with modified elasticity |
ATE459659T1 (de) * | 2006-11-07 | 2010-03-15 | Dsm Ip Assets Bv | Carbamat, thiocarbamat oder carbamid mit einer biomolekularen gruppierung |
US8318695B2 (en) * | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
JP5435536B2 (ja) * | 2008-09-04 | 2014-03-05 | 学校法人神奈川大学 | 光分解性ブロックコポリマー |
JP5846404B2 (ja) | 2010-10-14 | 2016-01-20 | 国立研究開発法人産業技術総合研究所 | 光分解性ゲル、細胞培養器具、細胞配列・分別装置、細胞配列方法および細胞分別方法 |
JP5783593B2 (ja) * | 2010-12-17 | 2015-09-24 | 国立研究開発法人産業技術総合研究所 | 細胞分別用マイクロチップおよび細胞分別方法ならびに細胞分別装置 |
JP2014226088A (ja) * | 2013-05-22 | 2014-12-08 | 独立行政法人産業技術総合研究所 | 光および加水分解性架橋剤、光および加水分解性ゲル、細胞培養器具、細胞配列・分別装置、細胞配列方法、細胞分別方法、並びに、組織体形成方法 |
-
2014
- 2014-05-13 WO PCT/JP2014/062725 patent/WO2014188911A1/fr active Application Filing
- 2014-05-13 US US14/892,267 patent/US9908972B2/en active Active
- 2014-05-13 EP EP14801820.3A patent/EP3000836B1/fr not_active Not-in-force
- 2014-05-13 JP JP2015518193A patent/JP6056111B2/ja active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
EP3000836A4 (fr) | 2016-05-18 |
US9908972B2 (en) | 2018-03-06 |
JP6056111B2 (ja) | 2017-01-11 |
WO2014188911A1 (fr) | 2014-11-27 |
EP3000836A1 (fr) | 2016-03-30 |
US20160177030A1 (en) | 2016-06-23 |
JPWO2014188911A1 (ja) | 2017-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3000836B1 (fr) | Agent de réticulation photodégradable | |
US10954489B2 (en) | Liver-mimetic device and method for simulation of hepatic function using such device | |
EP3129494B1 (fr) | Compositions d'hydrogel destinées à être utilisées dans l'activation de la tubulogenèse | |
Pampaloni et al. | Three-dimensional cell cultures in toxicology | |
JP2014226088A (ja) | 光および加水分解性架橋剤、光および加水分解性ゲル、細胞培養器具、細胞配列・分別装置、細胞配列方法、細胞分別方法、並びに、組織体形成方法 | |
Sk et al. | Synthesis and characterization of site selective photo-crosslinkable glycidyl methacrylate functionalized gelatin-based 3D hydrogel scaffold for liver tissue engineering | |
US8741645B2 (en) | Test kit comprising a culture instrument with a cell pattern and a gel suitable to embed cell pattern | |
AU2008296981A1 (en) | Compliant surface multi-well culture plate | |
Guo et al. | Light activated cell migration in synthetic extracellular matrices | |
KR20130042854A (ko) | 세포 패터닝과 대사산물 검출의 기능을 가진 미세패턴된 다층 구조의 나노섬유 스캐폴드 | |
Porras Hernández et al. | A simplified approach to control cell adherence on biologically derived in vitro cell culture scaffolds by direct UV-mediated RGD linkage | |
Wang et al. | High-throughput hyaluronic acid hydrogel arrays for cell selective adhesion screening | |
Jang et al. | Non-cell adhesive hexanoyl glycol chitosan hydrogels for stable and efficient formation of 3D cell spheroids with tunable size and density | |
Otsuka et al. | Chondrocyte spheroids on microfabricated PEG hydrogel surface and their noninvasive functional monitoring | |
Pandala et al. | Screen printing tissue models using chemically cross-linked hydrogel systems: a simple approach to efficiently make highly tunable matrices | |
US20120309089A1 (en) | Supports for cell culture and cell sheet detachment and methods for cell sheet detachment | |
US8592139B2 (en) | Test method using cells and test kit therefor | |
US11597909B2 (en) | Method for the formation of renal tubules | |
Angres et al. | 3‐D Life biomimetic hydrogels: A modular system for cell environment design | |
Lavrentieva et al. | Hydrogels for 3D cell culture | |
JP7219891B2 (ja) | 細胞培養用積層体、医療器具および医療器具の使用方法 | |
Lee | Polyacrylamide Photo-responsive Hydrogels and Its Application in Cell Biology | |
WO2023235850A1 (fr) | Hydrogels à photo-motifs | |
Roth | Modeling Liver Diseases Using Hepatic Cell Microarrays | |
Westergren | Analysis of hydrogels for immobilisation of hepatocytes (HepG2) in 3D cell culturing systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20151118 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20160415 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C08G 81/00 20060101ALI20160411BHEP Ipc: C08G 69/26 20060101ALI20160411BHEP Ipc: C12M 3/04 20060101ALI20160411BHEP Ipc: C12M 1/00 20060101ALI20160411BHEP Ipc: C12N 1/00 20060101ALI20160411BHEP Ipc: C08G 63/12 20060101ALI20160411BHEP Ipc: C08G 65/333 20060101AFI20160411BHEP Ipc: C12N 5/00 20060101ALI20160411BHEP |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20180814 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: SUGIURA SHINJI Inventor name: SUMARU KIMIO Inventor name: KANAMORI TOSHIYUKI Inventor name: YANAGAWA FUMIKI Inventor name: TAKAGI TOSHIYUKI |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1081316 Country of ref document: AT Kind code of ref document: T Effective date: 20190115 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014038755 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190326 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190326 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20181226 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190327 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1081316 Country of ref document: AT Kind code of ref document: T Effective date: 20181226 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190426 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190426 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014038755 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20190927 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20190531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190513 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190513 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20140513 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20220321 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20220325 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181226 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20220321 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20220405 Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602014038755 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20230513 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230531 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231201 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230513 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230531 |